FFA
QNTM

Farther Finance Advisors’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Farther Finance Advisors’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62K Hold
1,000
– – ﹤0.01% 4951
2026
Q1 		$4.41K Hold
1,000
– – ﹤0.01% 4559
2025
Q4 		$7.3K Buy
+1,000
New +$10.9K ﹤0.01% 4110

Other funds holding QNTM

PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Farther Finance Advisors's QNTM Position: Q2 2026 in Review

Farther Finance Advisors held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q2 2026 at 1,000 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #4951.

Farther Finance Advisors first reported a position in QNTM in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.3K in Q4 2025. 8 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

  • Farther Finance Advisors held 1,000 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $3.62K as of Q2 2026.
  • Farther Finance Advisors left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q2 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4951 holding.
  • Farther Finance Advisors first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $7.3K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.